Navigation Links
Advanced Life Sciences to Host 2009 Third Quarter Financial Results Conference Call and Webcast
Date:11/4/2009

CHICAGO, Nov. 4 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), announced today that it will host a conference call and webcast discussing the Company's 2009 third quarter results on Tuesday, November 10, 2009 at 10:00 a.m. (EST). Michael T. Flavin, Ph.D., Chairman & Chief Executive Officer, as well as other members of the management team, will also present an update on the Company. A press release reporting the 2009 third quarter results will be issued before the U.S. stock markets open on Tuesday, November 10, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 888.713.4214 (domestic) or 617.213.4866 (international). The passcode for the conference call is 75545191. A replay of the conference call will be available until November 17, 2009. Callers may access the telephone replay by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 79025053. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PGFUTHTV6. Pre-registrants will be issued a pin number to use when dialing into the live call which will provide quick access to the conference by bypassing the operator upon connection.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the disco
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
2. Advanced Life Sciences to Present at 8th Annual BIO Investor Forum
3. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
4. Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel
5. Advanced Health Media Named to 2009 InformationWeek 500 List of Top Technology Innovators Across America
6. Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
7. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
8. Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer
9. Hanson Technologies, Inc. Awarded Patent for its Advanced Food Pathogen Detection System
10. Advanced Instruments Introduces Next-Generation Web Site
11. New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...if.,Nov.24/PRNewswire/--Twomoreprestigiousuniversi...linejobboardandcareerssiteforlifescienceprofession...membersofthejobboard,joining28othermajorlifescienc...areercenter.com ,isonlyforpost-graduatesinthelifes...tesontheInternet,BioCareerCenteristheonlyonethatse...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs ...show consistent growth during the U.S. recession. ... trouble, and health systems are coming closer to ...of just administrators. , ...nt continued growing in October despite the sheddi...
(Date:11/24/2009)...24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,C...rovedthe,investigationalnewdrugapplication(IND)for...formulationtotreatdiabetes.ThisIND,approvalallowsB..., Diabetesisadisordercharacteristicofhighbloodgluc...tenresultinseveremicro-and,macro-vasculardiseases,...
(Date:11/24/2009)...L , TORONTO,Nov.24/PRNewswire-FirstCall/-Hami...c.,aleadingproviderofadvancedlasersystemsandinstru...ts,todayreportedoperationalandfinancialresultsfort...hlights,-Revenuewas$1.46millioncomparedwith$1.43m...paredwith66.1percentinQ3,2008,-Netlossreducedto$14...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...nc. (NYSE: BRL ) today confirmed that its subsidi...enge of the patent listed by Forest,Laboratories, ...hydrochloride) tablets, 5mg and 10mg., Barr filed...ining a,paragraph IV certification for a generic N...ation (FDA) on October 16, 2007, the first date th...
...asdaq: MAXY ), a biotechnology company focused on...announced that it will present at the,Stanford Gro...ursday,January 17, 2008 at 7:45 a.m. Eastern Time...., will present. A live webcast of the presentation...ww.maxygen.com/webcasts . A replay,of the presenta...
...a biomaterials, medical device and tissue processi...ied that a lawsuit will be filed against it in,the...o a meniscal,allograft., The lawsuit concerns an ... transplant of a meniscal allograft in December 20...ients with significant damage to the,knee, who hav...
Other Biology Technology:Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 2Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 3CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney 2CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney 3
(Date:11/25/2009)...ersity assistant professors recently received fund...continue research beneficial to understanding the ...Christopher Blackwood, assistant professor in the ...nts to support two separate research projects. , ...mposer Communities and Functions from the Leaf to ...
(Date:11/24/2009)...Institute (LRI) today named 12 new grant recipient...ognize innovative work across a broad spectrum of ...vity, novelty, and potential to drive scientific d...e complex disease of systemic lupus. , The 2009 ...chers across the nation and include interdisciplin...
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 1Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 2Essentialis to Submit SPA for Hypertriglyceridemia 4847 1Essentialis to Submit SPA for Hypertriglyceridemia 4847 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 1Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 3
...can act as an antioxidant when incorporated into p...the incidence of cancers -- notably lung, colorect...o know how the mechanism works, and that,s not tri...tion at the University of Illinois at Chicago and ...nary study set up at UIC to help answer that quest...
...nstitute (VBI) at Virginia Tech have developed a c...r understand the metabolism and toxicity of the HI...AZT is used successfully as part of Highly Active ...el of the human immunodeficiency virus in HIV-infe...y lead to side-effects in some patients. David Sam...
...ntire superfamily of nuclear receptors ?proteins t...Southwestern Medical Center researchers found that...egulate disease states and physiology in two main ...eptor networks also have key roles in metabolism,s...ings, published today in two studies in the journa...
Other Biology News:Selenium-protein deficiency raises prostate cancer risk 2Computational model simulates AZT metabolism in mitochondria 2First 'encyclopedia' of nuclear receptors reveals organisms' focus on sex, food 2First 'encyclopedia' of nuclear receptors reveals organisms' focus on sex, food 3
Toxoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
Agarose, low melting/gelling temperature high MW separation (> 1000 bp) from GE Healthcare, formerly Amersham Biosciences
Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
Chlamydia pneumonia IgA ELISA Kit, Single from Bio-Quant Inc.
Biology Products: